225 related articles for article (PubMed ID: 35390349)
1. Skin Microbiome Variation with Cancer Progression in Human Cutaneous Squamous Cell Carcinoma.
Voigt AY; Emiola A; Johnson JS; Fleming ES; Nguyen H; Zhou W; Tsai KY; Fink C; Oh J
J Invest Dermatol; 2022 Oct; 142(10):2773-2782.e16. PubMed ID: 35390349
[TBL] [Abstract][Full Text] [Related]
2. Reduced Staphylococcus Abundance Characterizes the Lesional Microbiome of Actinic Keratosis Patients after Field-Directed Therapies.
Kehrmann J; Koch F; Zumdick S; Höwner A; Best L; Masshöfer L; Scharfenberg S; Zeschnigk M; Becker JC; Schadendorf D; Buer J; Roesch A
Microbiol Spectr; 2023 Jun; 11(3):e0440122. PubMed ID: 37212689
[TBL] [Abstract][Full Text] [Related]
3. A Natural History of Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Microbiomes.
Wood DLA; Lachner N; Tan JM; Tang S; Angel N; Laino A; Linedale R; Lê Cao KA; Morrison M; Frazer IH; Soyer HP; Hugenholtz P
mBio; 2018 Oct; 9(5):. PubMed ID: 30301852
[TBL] [Abstract][Full Text] [Related]
4. The cutaneous microbiome in skin cancer - A systematic review.
Ding R; Lian SB; Tam YC; Oh CC
J Dtsch Dermatol Ges; 2024 Feb; 22(2):177-184. PubMed ID: 38243841
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of enhancer of Zeste Homolog 2 (EZH2) differentiates squamous cell carcinoma from normal skin and actinic keratosis.
Xie Q; Wang H; Heilman ER; Walsh MG; Haseeb MA; Gupta R
Eur J Dermatol; 2014; 24(1):41-5. PubMed ID: 24413452
[TBL] [Abstract][Full Text] [Related]
6. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
Feldman SR; Fleischer AB
Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
[TBL] [Abstract][Full Text] [Related]
7. Clinical comparison of actinic changes preceding squamous cell carcinoma vs. intraepidermal carcinoma in renal transplant recipients.
Jiyad Z; O'Rourke P; Soyer HP; Green AC
Clin Exp Dermatol; 2017 Dec; 42(8):895-897. PubMed ID: 28925042
[TBL] [Abstract][Full Text] [Related]
8. Targeting
Bromfield JI; Hugenholtz P; Frazer IH; Khosrotehrani K; Chandra J
Front Oncol; 2023; 13():1091379. PubMed ID: 36816953
[TBL] [Abstract][Full Text] [Related]
9. Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis.
Dinehart SM; Nelson-Adesokan P; Cockerell C; Russell S; Brown R
Cancer; 1997 Mar; 79(5):920-3. PubMed ID: 9041154
[TBL] [Abstract][Full Text] [Related]
10. Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
de Oliveira Poswar F; de Carvalho Fraga CA; Gomes ES; Farias LC; Souza LW; Santos SH; Gomez RS; de-Paula AM; Guimarães AL
Int J Surg Pathol; 2015 Feb; 23(1):20-5. PubMed ID: 24984957
[TBL] [Abstract][Full Text] [Related]
11. Exposome and Skin. Part 2. The Influential Role of the Exposome, Beyond UVR, in Actinic Keratosis, Bowen's Disease and Squamous Cell Carcinoma: A Proposal.
Molina-García M; Malvehy J; Granger C; Garre A; Trullàs C; Puig S
Dermatol Ther (Heidelb); 2022 Feb; 12(2):361-380. PubMed ID: 35112326
[TBL] [Abstract][Full Text] [Related]
12. Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model.
Zalaudek I; Giacomel J; Schmid K; Bondino S; Rosendahl C; Cavicchini S; Tourlaki A; Gasparini S; Bourne P; Keir J; Kittler H; Eibenschutz L; Catricalà C; Argenziano G
J Am Acad Dermatol; 2012 Apr; 66(4):589-97. PubMed ID: 21839538
[TBL] [Abstract][Full Text] [Related]
13. Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression.
Padilla RS; Sebastian S; Jiang Z; Nindl I; Larson R
Arch Dermatol; 2010 Mar; 146(3):288-93. PubMed ID: 20231500
[TBL] [Abstract][Full Text] [Related]
14. Expression of MCM2 as a Proliferative Marker in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.
Rymsza A; Świerczyńska K; Piotrowska A; Dzięgiel P; Szepietowski JC
In Vivo; 2022; 36(3):1245-1251. PubMed ID: 35478139
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
16. Risk of squamous cell carcinoma in immunosuppressed patients with voriconazole-related actinic keratosis.
Nobeyama Y; Umezawa Y; Asahina A
J Dermatol; 2022 Nov; 49(11):1168-1172. PubMed ID: 35986452
[TBL] [Abstract][Full Text] [Related]
17. High-definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma.
Boone MA; Marneffe A; Suppa M; Miyamoto M; Alarcon I; Hofmann-Wellenhof R; Malvehy J; Pellacani G; Del Marmol V
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1606-15. PubMed ID: 25656269
[TBL] [Abstract][Full Text] [Related]
18. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.
Karagece Yalçin U; Seçkın S
Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629
[TBL] [Abstract][Full Text] [Related]
19. Comparison of oxidative stress on DNA, protein and lipids in patients with actinic keratosis, Bowen's disease and squamous cell carcinoma.
Yoshifuku A; Fujii K; Kanekura T
J Dermatol; 2018 Nov; 45(11):1319-1323. PubMed ID: 30222205
[TBL] [Abstract][Full Text] [Related]
20. The current role of in vivo reflectance confocal microscopy within the continuum of actinic keratosis and squamous cell carcinoma: a systematic review.
Nguyen KP; Peppelman M; Hoogedoorn L; Van Erp PE; Gerritsen MP
Eur J Dermatol; 2016 Dec; 26(6):549-565. PubMed ID: 28007674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
